000			03847cam a2200385Ii 4500
001			95716
003			ES-MaUEC
005			20230102112718.0
006			m o d
007			cr cnu|||unuuu
008			170403s2017 sz a o 001 0 eng d
020			_a3319530828 _q(electronic bk.)
020			_a9783319530826 _q(electronic bk.)
020			_z331953081X
020			_z9783319530819
040			_aN$T _cN$T _dGW5XE _dN$T _dYDX _dN$T _dNJR _dOCLCF _dCOO _dAZU _dUPM _dOCLCQ _dUAB _dES-MaUEC _bspa
050		4	_aRC268.4 _bM654 2017 EB
245	0	0	_aMolecular oncology : _bunderlying mechanisms and translational advancements _cAmmad Ahmad Farooqi, Muhammad Ismail, editors.
264		1	_aCham, Switzerland _bSpringer _c2017.
300			_a1 recurso en línea (x, 302 páginas) _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF _2rda
500			_aIncluye índice
500			_aSpringerLink _bSpringer Biomedical and Life Sciences eBooks 2017 English+International
505	0		_aMicrotubule targeting agents in cancer therapy: Elucidating the underlying molecular mechanisms -- Adenosine signaling pathways as potential therapeutic targets in cancer disease -- Anticancer activities of Hippophae rhamnoides: Journey from Benchtop to the Bedside -- Emerging role of ncRNAs in cancer biology: techniques for diagnostic monitoring and potential ncRNA-based therapies -- Clinical and translational research on the pathophysiology of several ocular tumors types -- Exosomes and cancer: from diagnosis to therapy -- Blood-based Cancer Detection: Towards Solving Diagnostic Puzzle -- Non-coding RNAs, Critical Therapy Targets against Cancer -- Detection of Virus-caused Cancer in Publicly Available Next Generation Sequencing Data -- TRAIL mediated signaling in prostate cancer -- Index.
520	3		_aCancer is a multifaceted and genomically complex disease and data obtained through high throughput technologies has provided near complete resolution of the landscape of how genomic, genetic and epigenetic mutations in cancerous cells effectively influence homeostasis of signaling networks within these cells, between cancerous cells, tumor microenvironment and at the organ level. Increasingly sophisticated information has helped us in developing a better understanding of the underlying mechanisms of cancer, and it is now known that intra-tumor genetic heterogeneity, cellular plasticity, dysregulation of spatio-temporally controlled signaling cascades, and loss of apoptosis are contributory in cancer development, progression and the development of resistance against different therapeutics. It is becoming progressively more understandable that earlier detection of pre-existing or emerging resistance against different therapeutics may prove to be helpful in personalizing the use of targeted cancer therapy. Despite the fact that there is a continuously increasing list of books, being guest edited by researchers, books on the subject are often composed of invited reviews without proper sequence and continuity and designed for a particular readership. This book progressively shifts and guides the readers from basic underlying mechanisms to translational approaches to treat cancer.
650		7	_aCancer _xMolecular aspects. _2fast _0(OCoLC)fst00845397 _9139308 _0comprobar BNE19900970859
700	1		_aFarooqi, Ammad Ahmad, _eeditor literario
700	1		_aIsmail, Muhammad, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-53082-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aEBOOK, asignarmaterias, EBSPRINGER_2017C
998			_b02/2018 _dz _e- _zSI
999			_c95716 _d95716 _x1